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Fas antigen, which belongs to a nerve growth factor / 
tumor necrosis factor receptor superfamily, is a mem-
brane protein that induces apoptosis. In humans, dis-
tribution ofFas antigen has been reported on cell lines 
and lymphocytes. Immunohistochemical studies re-
vealed Fas antigen on the keratinocytes of lesional 
epidermis in lichenoid drug eruption, erythema mul-
tiforme, contact dermatitis, bullous pemphigoid, 
pemphigus vulgaris, and herpes zoster; it is co-ex-
pressed with intercellular adhesion molecule-1. Cul-
tured keratinocytes expressing Fas antigen increased 
A PoPtosiS, programmed cell death, occurs in embryo-genesis, metamorphosis, tissue atrophy, and tumor re-gression [1,2]. It is clearly distinguished from cel l death or necrosis resulting from complement attack, hyperthermia, hypoxia, or other severe environmen-
tal conditions. Apoptosis is morphologically and biochemically 
characterized by condensation of the cell, loss of plasma membrane 
microvilli, shrinking and segmentation of the nucleus, and exten-
sive oegradation of chromosomal DNA. A ladder pattern of DNA 
may be produced by activation of endogenous endonucleases [3] . 
Recently, genetic regulation of apoptosis by p53, bcl-2, and c-myc 
have been reported [4-10]. 
In the immune system, apoptosis plays an important role in clonal 
deletion of self-reactive T cells in the thymus [11] and in the selec-
tion of lymphocytes in the peripheral blood [12,13]' Apoptosis has 
also been documented in pathogenetic conditions such as the death 
of T cells in human immunodeficiency virus infection [14] or of 
eosinophils isolated from atopic patients [15] . Radiation, glucocor-
ticoids, tumor necrosis factor, leucyl-Ieucine methyl ester, and frag-
mentin have also been reported to cause apoptosis [16-20]. Cyto-
kine signals from the environment such as interferon (IFN)-y, 
interleukin (IL)-2, IL-5, and IL-6 are known to modulate apoptosis 
[8,15,21-23]. 
Fas antigen, a transmembrane molecule mediating apoptosis, be-
longs to a nerve growth factor/tumor necrosis factor receptor su-
perfamily [23 - 25]. Monoclonal antibody (MoAb) anti-Fas has been 
shown to cause apoptosis in cells expressing Fas antigen [23]. When 
the cDNA ofFas antigen was expressed in murine cells, they under-
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from 8.4% to 34.6% after stimulation with interferon 
gamma for 24 h. Treatment of interferon-gamma-
stimulated keratinocytes with anti-Fas for 48 h re-
sulted in DNA fragmentation and death of32% of cells, 
suggesting that Fas antigen may mediate apoptosis. 
The expression of Fas antigen on keratinocytes in le-
sional skin suggests that death via Fas antigen may play 
an important role in the pathogenesis of keratinocyte 
cytotoxicity. Key words: intercellular adhesion molecule-1/ 
interferon gamma/tumor necrosis factor /membrafle proteiru/ 
cell survival.] Iflvest DermatoI103:330-334, 1994 
went apoptotic death [24). Although the physiologic ligand for Fas 
antigen has not been found, a surface molecule of T cells has been 
suggested as a candidate [26]. APO-1 has been found to be identical 
with Fas antigen [27 ,28). 
Fas antigen mRNA in mouse was expressed in a limited number 
of tissues, including the thymus, liver, ovary, and heart [25]. In 
humans, Fas antigen was demonstrated in cultured cells and freshly 
isolated lymphocytes [22,29), but its distribution on epithelial cells 
or other cells in vivo has not been well studied. Among diseases, only 
a lymphoproliferative disorder in the mouse has been shown to be 
related to Fas antigen (30). A recent study has shown that anti-Fas 
has lethal effects in the mouse [31] . 
Apoptosis of epidermal keratinocytes was recently reviewed in 
detail [32] and is known to be an important feature in lichenoid 
tissue reaction, fixed drug eruption, graft-versus-host reaction, and 
the effect of ultraviolet radiation [33] . The purpose of this study was 
to clarify whether Fas antigen is involved in keratinocyte apoptosis. 
In vivo expression of Pas antigen was studied immunohistochemi-
cally and functionally in cultured keratinocytes. We show that Fas 
antigen is expressed on keratinocytes of lesional epidermis and 011 
interferon-gamma (IFN-Y) -stimulated keratinocytes and that 
apoptosis is induced by anti-Fas antibody. 
MATERIALS AND METHODS 
Patients Skin specimens were obtained from a total of 31 patients: five 
cases of lichenoid drug eruption, six cases of erythema multiforme (dermal 
type), six cases of bullous pemphigoid, five cases of pemphigus vulgaris, six 
cases of contact dermatitis, and three cases of herpes zoster. Nonlesiollal 
human skin was obtained from plastic surgery specimens. 
Immunohistochemical Studies After fixing with cold acetone and 
blocking with I-IIO., we stained 4-llm frozen sections in OCT compound 
with MoAb anti-Fas (CH-11; igM [23]), MoAb anti-intercellular adhesion 
molecule-1 (iCAM-1; Cosmo Bio Co. Inc., Tokyo, Japan) or control MoAb 
(umelev3nt IgM or IgG,) using a streptavidin-biotin-peroxidase staining kit 
(Nichirei Co. inc., Tokyo,Japan). Background staining with control MoAb 
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Table I. Expression ofFas Antigen and ICAM-1 on the 
Keratinocytes of Lesional Epidermis· 
Fas Antigen ICAM-1 
Disease Intensityb Positive' Intensity Positive 
Nonlesiona l skin -/± 0/5 -/± 0/5 
Lichenoid drug eruption - /++ 4/5 ±/+++ 3/5 
Erythema multiforme +/++ 6/6 ++/+++ 6/6 
Contact dermatItIs +/++ 6/6 ±/++ 3/6 
Bullous pemphigoid ±/+ 5/6 -/+ 1/6 
Pemphigus vulgans -/+ 2/5 -/+ 1/5 
Herpes zoster +++ 3/3 +++ 3/3 
• Frozen sections were immunohistochemically stained. The staining intensity of the 
epiderm al keratinocytes was rated as -, ±, +, ++, or +++. 
" A range of intensIty. . .. 
, Positive/total. Intensity of more than + was desIgnated as positive. 
was negligible. The intensity of the staining was rated as -, ±, +? ++, 
or +++, among which those of more than + were shown as posltlve 111 
Table I. 
Cell Culture Human foreskin keratinocytes and serum-free culture me-
d·wn containing 0.08 m.M Ca++, extracts of bovine pituitary, and epidermal g~owth factor were obtained from Morinaga Institute of Biological Science 
(Yokohama, Kanagawa, Japan) and cultured at 37°C in a humidified atmo-
sphere containing 5% CO2 . Cells were used for the expcnmcnt when thcy 
reached semiconfluencc. 
Flow Cytometry Cultured keratinocytcs :-rere removed from the culture 
bottles by incubation wI~h tryPS1l1/ ~thyl enedlamU1etetraacetlc aCid (EDT A) 
(Morinaga Institute of BIOlogical SCIence) for a ~ew mU1utes (Fas antIgen was 
sensitive to tryps1l1/EDTA) , and 10% feta l bov1I1e serum was added to stop 
the action of trypsin. All of the following procedures were performed at 
4°C. The cells were washed and resuspended in phosphate-buffered saline 
(PBS) containing 1.0% bovine serum albumin and 0.1 % sodium azide. The 
cells (2 X 105) were incubated with 50 JiI of pnmary M?A.b fo~ 30 nun, 
washed, incubated with 50 Jil of 1 : 50 dtlutlon of fluoresce1l1lsot!110cyanate 
(FITC)-conjugated goat anti-mouse IgG ~nd IgM (TAGO Co. Inc., Burhn-
game, CAl for 30 min, washed, and then resuspended in 500 til of the same 
buffer for analysis. The fluorescence was measured by EPICS Profile 
(Coulter Co. Inc. , Hialeah, FL). The data ~ere presented as percent posltlve 
ceils , reflecting percent of the cells wIth fluorescence above control 
« 0 .5%). 
Cells from each condition were stained with MoAb anti-Fas, MoAb anti -
ICAM-l, and irrelevant MoAb (IgM or IgG,) as controls. The second anti-
body was absorbed with an equal volume of packed cultured keratinocytes at 
4°C for 1 h. 
Induction of Cell Death by Anti-Fas When cells became semicon-
fluent, they were cultured with or without recombinant human IFN-y 
(Shionogi & Co. Ltd., Osak~,Japan) at a concentration of l OJ U / ml for ~4 h. 
After washing the cells twIce wIth PBS and once wIth cul ture medIUm, 
anti-Fas was added at a final concentration of 1 Jig/ml, and the culture was 
continued for an additional 48 h at 37°C. At this time cel ls werc confluent 
except for those treated with IFN-y and anti-Fas, some of which had de-
tached from the culture surface. As control, MoAb anti-CD46 (M-1 77, 
IgG,), which bound to the keratinocyte cell surface (34] , was added. Cells 
detached during the 48-h perIod were recovered by collecting the culture 
medium and PBS used for rinsing the cultures. Remaining adherent cells 
were collected as described above using flow cytometry. The viability of cel ls 
was determined by trypan blue exclusion. The percent of the dead cells was 
expressed as the percent of th ~ total cells i~lCludillg both the d~tached and 
remaining adherent cells. StatIstIcal analySIS was performed US111g the Stu-
dent t test. 
To assess DNA fragmentation, we isolated genomic DNA frol11 approxi-
mately 3 X t 06 cells of each condition described above using a DNA extrac-
tion kit (Sankojunyaku Co. Ltd., Tokyo, Japan) and analyzed it on a 2.0% 
agarose gel stained with ethidium bromide. 
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RESULTS 
Immunohistochemical studies showed that Fas antigen was ex-
pressed on keratinocytes from lesiona l epidermis in most cases (Fig 
1, Table I) . The staining intensity was higher in lichenoid drug 
eruption, erythema multiforme, contact dennatitis, and herpes zos-
ter than in bullous pemphigoid and pemphigus vulgaris. Keratino-
cytes of nonl esional epidermis, obtained from patients w ithout in-
flammation after plastic surgery, showed only faint or no expression 
of Fas antigen. The keratinocytes also expressed ICAM-t (Fig 1), 
and the intensity was similar to that ofFas antigen. The distribution 
ofICAM-l, however, was localized to the basal cell layer, except for 
erythema multiforme, as reported previously [33]. 
By flow cytometry, anti-Fas - positive cells were 8.4% in unstimu-
lated keratinocytes and increased to 34.6% after stimulation with 
IFN-y for 24 h (Fig 2). ExpressionofFas antigen and ICAM-l after 
exposure to different concentrations of IFN-y are shown in 
Fig 3. The expression ofICAM-l increased from 0.5% to 97.0%. 
IFN-y-stimulated keratinocytes were killed by anti-Fas anti-
body. IFN-y-stimulated cells started to detach from the culture 
surface on the second day after exposure to anti-Fas antibody, and 
the dead cells from both detached and remaining cells increased 
from 10.2% to 31.7% (Fig 4). Although detached cells increased 
with anti-Fas antibody in unstimulated cells, the percentage of dead 
cells did not increase. 
DNA fragmentation was observed only on cells treated with anti-
Fas antibody followed by IFN-y (Fig 5) . Treatment with anti-Fas 
antibody or IFN-y alone did not lead to DNA fragmentation. 
DISCUSSION 
Immunohistochemical studies revealed expression ofFas antigen on 
the keratinocytes of lesional epidermis in a range of inflammatory 
diseases, the pathogenetic mechanisms of which were entirely dif-
ferent, such as virus infection, lymphocyte attack on basal cells, 
autoantibodies, or delayed-type hypersensitivity. Fas antigen and 
ICAM-1 were co-expressed on these keratinocytes. Variation in 
staining intensity among the diseases suggested that Fas antigen 
might not always be required to cause keratinocyte damage or 
ICAM-1 expression. Expression of Fas antigen can be induced by 
IL-2 or IFN-y in lymphocytes o r cell lines [22,23], and induction of 
ICAM-1 on the keratinocytes in erythema mu ltiforme, contact der-
matitis, and lichenoid tissue reaction may be due to the action of 
IFN-y [35]. T his suggests that IFN-y might also induce the expres-
sion of Fas antigen on keratinocytes. 
Keratinocytes of nonlesional epidermis and unstimulated cul-
tured keratinocytes expressed minimal Fas antigen. The expression 
of Fas antigen was increased on cultured keratinocytes by stimula-
tion with IFN-y, but the increase was not as significant as that of 
rCAM- I. Tumor necrosis factor-a had no apparent effect on the 
expression of Fas antigen (data not shown). 
C ultured keratinocytes were susceptible to anti-Fas after treat-
ment w ith IFN-y, which can be explained by the increased ex-
pression of Fas antigen. Increased susceptibility by IFN-y in cell 
lines or IL-2 in lymphocytes was also observed [22,23]. In chronic 
B-cell lymphocytic leukemia, however, IFN-y inhibits apoptosis 
[21] . 
The process of apoptosis has been well studied in lymphocytes. 
The first event is DNA fragm.entation, which was observed in less 
th an 30 min [22]. Morphologic changes occur in several hours 
[23,24], followed by loss of membrane integrity. In IFN-y-
stimulated keratinocytes, morphologic changes were not observed 
by light microscopy during the first day of culture with anti-Fas 
antibody, and were not apparent even on the second day, when cells 
began to detach. This process is slower than that of lymphocytes. 
Apoptotic changes were noted in only 30% of keratinocytes. Dif-
ferent sensitivity to anti-Fas antibody has been observed in different 
cell types [23], in which dead cells varied from < 25% to > 75%. 
Epidermis can be a target in many immunologic reactions, al-
332 SAYAMA ET AL THE JOURNAL OF INVESTIGATIV.E DERMATOLOGY 
Figure 1. Keratinocytes of Ie siona 1 epidermis express Fas antigen and ICAM-1. Frozen sections were immunohistochemically stained with MoAb 
anti-Fas (a-e) or anti-I CAM (f- j). a,I. Nonlesional skin. b,g, Lichenoid drug eruption. c,h, Erythema multiforme. d,i, Bullous pemphigoid. e,j, Herpes zoster, 
erythematous lesion. Scale bar, 50 j.lm. 
though the mechanism of the final step leading to the cell death is 
not yet clear. It is possible that disease-specific induction ofICAM-l 
is important in triggering these skin diseases and in determining the 
pattern of the diseases [35]. ICAM-l expression on human kerati-
nocytes can be induced by stimulation with IFN-y, TNF-Q, or ul-
traviolet radiation [35 - 371. Interactions between ICAM-l on kera-
tinocytes and LFA-l on leukocytes are considered to be important in 
cellular cytotoxicity [35,36]. In T-ceH-mediated cytotoxicity, tar-
get cells can be killed by apoptosis via Fas antigen [261. The ligand 
for Fas antigen is thought to be present on lymphocytes but has not 
yet been identified. Our data suggest a model of keratinocyte cyto-
toxicity by lymphocytes. First, lymphocytes attach to keratinocytes 
by means of ICAM-I. Subsequently, apoptosis of keratinocytes is 
triggered by the adherent lymphocytes via Fas antigen. 
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Figure 2. Fas antigen and ICAM-l expression on cultured keratino-
cytes increase after stimulation with IFN-y. Cells were cultured with or 
without IFN-y (10' U / ml) for 24 h and stained with MoAb followed by 
fluorescein isoth iocyanate-conjugated goat anti-mouse IgG and IgM. a, Un-
stimulated cells stained with control MoAb (solid litle) or anti-Fas (dotted 
lirle), and stimulated cells stained with anti-Fas (thick /itle). b, Unstimulated 
cells stained with control MoAb (solid litle) or anti-ICAM-l (dotted li tle) , 
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Figure 3. Fas-antigen- and ICAM-l- positive keratinocytes increase 
after stimulation w ith IFN-y. Cells were stimulated with different con-
centrations of IFN-y for 24 h, and analyzed by flow cytometry. 0, Fas 
antigen. 6, ICAM-1. • Increase is statistically significant (p < 0.01). 
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